Stanaway JD, Reiner RC, Blacker BF, Goldberg EM, Khalil IA, Troeger CE, et al. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2019;19:369–81. https://doi.org/10.1016/S1473-3099(18)30685-6.
Androulakis ES, Tousalis D, Papageorgiou N, Tsioufis C, Kallikazaros I, Stefanadis C. Essential hypertension: is there a role for inflammatory mechanisms? Cardiol Rev. 2009;17:216–21. https://doi.org/10.1097/CRD.0b013e3181b18e03.
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. https://doi.org/10.1093/eurheartj/ehy339.
Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circ. 2003;108:1546–51. https://doi.org/10.1161/01.CIR.0000088846.10655.E0.
Prado NJ, Ferder L, Manucha W, Diez ER. Anti-inflammatory effects of melatonin in obesity and hypertension. Curr Hypertens Rep. 2018;20:45. https://doi.org/10.1007/s11906-018-0842-6.
CAS Article PubMed Google Scholar
Russo I. The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired hemostasis and fibrinolytic balance. Scientifica (Cairo). 2012;2012:1–17. https://doi.org/10.6064/2012/525374.
Kallistratos MS, Poulimenos LE, Manolis AJ. Atrial fibrillation and arterial hypertension. Pharmacological Res. 2018;128:322–6. https://doi.org/10.1016/j.phrs.2017.10.007.
Katsimardou A, Imprialos K, Stavropoulos K, Sachinidis A, Doumas M, Athyros V. Hypertension in metabolic syndrome: novel insights. Curr Hypertens Rev. 2019;16:12–8. https://doi.org/10.2174/1573402115666190415161813.
Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, et al. Metabolic syndrome in the pressioni arteriose monitorate e loro associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertens. 2007;49:40–7. https://doi.org/10.1161/01.HYP.0000251933.22091.24.
Pannier B, Dé Rique Thomas F, Bean K, Jé B, Benetos A, Guize L. The metabolic syndrome: similar deleterious impact on all-cause mortality in hypertensive and normotensive subjects. J Hypertens. 2008;26:1223–1228. https://doi.org/10.1097/HJH.0b013e3282fd9936.
Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. J Am Coll Cardiol. 2020;75:2921–30. https://doi.org/10.1016/j.jacc.2020.04.038.
• Al Ghorani H, Götzinger F, Böhm M, Mahfoud F. Arterial hypertension – clinical trials update 2021. Nutr, Metabol Cardiov Dis. 2022;32:21–31. https://doi.org/10.1016/j.numecd.2021.09.007. This review summarizes relevant clinical trials related to age at hypertension onset and risk factors for cardiovascular disease in the future.
Marra AM, Bossone E, Salzano A, D’Assante R, Monaco F, Ferrara F, et al. Biomarkers in pulmonary hypertension. Heart Fail Clin. 2018;14:393–402. https://doi.org/10.1016/j.hfc.2018.03.005.
Colli LG, Belardin LB, Echem C, Akamine EH, Antoniassi MP, Andretta RR, et al. Systemic arterial hypertension leads to decreased semen quality and alterations in the testicular microcirculation in rats. Scientific Rep. 2019;9:11047. https://doi.org/10.1038/s41598-019-47157-w.
Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D. Obstructive sleep apnea, hypertension and cardiovascular diseases. J Hum Hypertens. 2015;29:705–12. https://doi.org/10.1038/jhh.2015.15.
CAS Article PubMed Google Scholar
Varvarousis D, Kallistratos M, Poulimenos L, Triantafyllis A, Tsinivizov P, Giannakopoulos A, et al. Cardiac arrhythmias in arterial hypertension. J Clin Hypertens. 2020;22:1371–8. https://doi.org/10.1111/jch.13989.
Buonacera A, Stancanelli B, Malatino L. Stroke and hypertension: an appraisal from pathophysiology to clinical practice. Curr Vasc Pharmacol. 2017;17:72–84. https://doi.org/10.2174/1570161115666171116151051.
Escobar E. Hypertension and coronary heart disease. J Hum Hypertens. 2002;16:61–3. https://doi.org/10.1038/sj/jhh/1001345.
Duca L, Blaise S, Romier B, Laffargue M, Gayral S, el Btaouri H, et al. Matrix ageing and vascular impacts: focus on elastin fragmentation. Cardiovasc Res. 2016;110:298–308. https://doi.org/10.1093/cvr/cvw061.
CAS Article PubMed Google Scholar
Cannatà A, Camparini L, Sinagra G, Giacca M, Loffredo FS. Pathways for salvage and protection of the heart under stress: novel routes for cardiac rejuvenation. Cardiovasc Res. 2016;111:142–53. https://doi.org/10.1093/cvr/cvw106.
CAS Article PubMed Google Scholar
Cencioni C, Spallotta F, Martelli F, Valente S, Mai A, Zeiher AM, et al. Oxidative stress and epigenetic regulation in ageing and age-related diseases. Int J Mol Sci. 2013;14:17643–63. https://doi.org/10.3390/ijms140917643.
CAS Article PubMed PubMed Central Google Scholar
Nosalski R, Guzik TJ. Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol. 2017;174:3496–513. https://doi.org/10.1111/bph.13705.
CAS Article PubMed PubMed Central Google Scholar
Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123:849–67. https://doi.org/10.1161/CIRCRESAHA.118.311378.
CAS Article PubMed PubMed Central Google Scholar
Tchalla AE, Wellenius GA, Travison TG, Gagnon M, Iloputaife I, Dantoine T, et al. Circulating vascular cell adhesion molecule-1 is associated with cerebral blood flow dysregulation, mobility impairment, and falls in older adults. Hypertens. 2015;66:340–6. https://doi.org/10.1161/HYPERTENSIONAHA.115.05180.
Laurent S, Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circ Res. 2015;116:1007–21. https://doi.org/10.1161/CIRCRESAHA.116.303596.
CAS Article PubMed Google Scholar
Laurent S, Briet M, Boutouyrie P. Large and small artery cross-talk and recent morbidity- mortality trials in hypertension. Hypertens. 2009;54:388–92. https://doi.org/10.1161/HYPERTENSIONAHA.109.133116.
Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE, et al. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-κB. Circ Res. 2007;100:1659–66. https://doi.org/10.1161/01.RES.0000269183.13937.e8.
CAS Article PubMed Google Scholar
• Mengozzi A, Nicola RP, Pugliese R, Chiriacò M, Masi S, Virdis A, et al. Microvascular ageing links metabolic disease to age-related disorders: the role of oxidative stress and inflammation in promoting microvascular dysfunction. J Cardio Pharmacol. 2021;78:S78–87. https://doi.org/10.1097/FJC.0000000000001109. (This review explores the relationship between microvascular dysfunction and aging process on metabolic disorders induced by inflammation and oxidative stress.)
Vanhoutte PM, Shimokawa H, Feletou M, Tang EHC. Endothelial dysfunction and vascular disease – a 30th anniversary update. Acta Physiol. 2017;219:22–96. https://doi.org/10.1111/apha.12646.
Donato AJ, Gano LB, Eskurza I, Silver AE, Gates PE, Jablonski K, et al. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2009;297:425–32. https://doi.org/10.1152/ajpheart.00689.2008.
Ganz P, Vita JA. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation. 2003;108:2049–53. https://doi.org/10.1161/01.CIR.0000089507.19675.F9.
Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002;90:1159–66. https://doi.org/10.1161/01.RES.0000020401.61826.EA.
CAS Article PubMed Google Scholar
Sehgel NL, Sun Z, Hong Z, Hunter WC, Hill MA, Vatner DE, et al. Augmented vascular smooth muscle cell stiffness and adhesion when hypertension is superimposed on aging. Hypertens. 2015;65:370–7. https://doi.org/10.1161/HYPERTENSIONAHA.114.04456.
Wirth A, Wang S, Takefuji M, Tang C, Althoff TF, Schweda F, et al. Age-dependent blood pressure elevation is due to increased vascular smooth muscle tone mediated by G-protein signalling. Cardiovasc Res. 2016;109:131–40. https://doi.org/10.1093/cvr/cvv249.
CAS Article PubMed Google Scholar
Morrell NW, Bloch DB, ten Dijke P, Goumans MJTH, Hata A, Smith J, et al. Targeting BMP signaling in cardiovascular disease and anaemia. Nat Rev Cardiol. 2016;13:106–20. https://doi.org/10.1038/nrcardio.2015.156.
CAS Article PubMed Google Scholar
Mikolajczyk TP, Nosalski R, Szczepaniak P, Budzyn K, Osmenda G, Skiba D, et al. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. FASEB J. 2016;30:1987–99. https://doi.org/10.1096/fj.201500088R.
CAS Article PubMed PubMed Central Google Scholar
Merino D, Villar AV, García R, Tramullas M, Ruiz L, Ribas C, et al. BMP-7 attenuates left ventricular remodeling under pressure overload and facilitates reverse remodeling and functional recovery. Cardiovasc Res. 2016;110:331–45. https://doi.org/10.1093/cvr/cvw076.
CAS Article PubMed Google Scholar
Wu J, Saleh MA, Kirabo A, Itani HA, Montaniel KRC, Xiao L, et al. Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Investig. 2016;126:50–67. https://doi.org/10.1172/JCI80761.
Schramm A, Matusik P, Osmenda G, Guzik TJ. Targeting NADPH oxidases in vascular pharmacology. Vasc Pharmacol. 2012;56:216–31. https://doi.org/10.1016/j.vph.2012.02.012.
Harvey A, Montezano AC, Touyz RM. Vascular biology of ageing-implications in hypertension. J Mol Cell Cardiol. 2015;83:112–21. https://doi.org/10.1016/j.yjmcc.2015.04.011.
留言 (0)